The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross-sectional study in general practice

Paul Connolly; Margaret E Cupples; Hazel Cuene-Grandidier; Dennis Johnston; Peter Passmore

doi:10.1002/pds.709

The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross-sectional study in general practice

Paul Connolly, Margaret E Cupples, Hazel Cuene-Grandidier, Dennis Johnston, Peter Passmore

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

To compare levels of recorded risk factors and drug treatment between patients with validated and non-validated diagnoses of coronary heart disease (CHD) in Northern Ireland.

Original language	English
Pages (from-to)	311-7
Number of pages	7
Journal	Pharmacoepidemiology and Drug Safety
Volume	11
Issue number	4
DOIs	https://doi.org/10.1002/pds.709
Publication status	Published - 2002

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1002/pds.709

http://www.scopus.com/inward/record.url?eid=2-s2.0-0035986742&partnerID=8YFLogxK

Cite this

@article{04d5b45dffdf4ffc8df1be4c0075a5bb,

title = "The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross-sectional study in general practice",

abstract = "To compare levels of recorded risk factors and drug treatment between patients with validated and non-validated diagnoses of coronary heart disease (CHD) in Northern Ireland.",

author = "Paul Connolly and Cupples, {Margaret E} and Hazel Cuene-Grandidier and Dennis Johnston and Peter Passmore",

year = "2002",

doi = "10.1002/pds.709",

language = "English",

volume = "11",

pages = "311--7",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention

T2 - a cross-sectional study in general practice

AU - Connolly, Paul

AU - Cupples, Margaret E

AU - Cuene-Grandidier, Hazel

AU - Johnston, Dennis

AU - Passmore, Peter

PY - 2002

Y1 - 2002

N2 - To compare levels of recorded risk factors and drug treatment between patients with validated and non-validated diagnoses of coronary heart disease (CHD) in Northern Ireland.

AB - To compare levels of recorded risk factors and drug treatment between patients with validated and non-validated diagnoses of coronary heart disease (CHD) in Northern Ireland.

U2 - 10.1002/pds.709

DO - 10.1002/pds.709

M3 - Article

C2 - 12138599

SN - 1053-8569

VL - 11

SP - 311

EP - 317

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 4

ER -

The importance of validating the diagnosis of coronary heart disease when measuring secondary prevention: a cross-sectional study in general practice

Abstract

ASJC Scopus subject areas

Access to Document

Fingerprint

Cite this